Back to Agenda
Session 1 Plenary: Advancing Regulatory Innovation: Canada’s Role in Global Collaboration
Session Chair(s)
Tharany Ganesh, MSc
Head, Regulatory Affairs
AstraZeneca Canada Inc., Canada
Katalin Bertenyi, MSc
Manager, Centre for Blood, Blood Products and Biotherapeutics
Health Canada, Canada
This session will provide an in-depth exploration of Health Canada’s current and future priorities including key regulatory initiatives. Attendees will gain insights into Health Canada engagement with international partners to advance regulatory collaboration on a global scale. The discussion will include diverse perspectives from industry representatives and patient groups, highlighting the collective impact of collaborative efforts on public health outcomes and regulatory innovation.
- Advancing Regulatory Innovation: Canada’s Role in Global Collaboration
Kelly Robinson, Health Canada - Enabling Faster Access and the Launch of Innovative Medicines and Vaccines
Jenny Buckley, Innovative Medicines Canada - Enhancing Patient Access to Therapies
Jessy Ranger, Myeloma Canada - What do the Metrics Tell Us
Neil McAuslane, Centre for Innovation in Regulatory Science (CIRS)
Learning Objective : At the conclusion of this session, participants should be able to:- Describe Health Canada’s current and future regulatory priorities and international collaboration pathways
- Understand key regulatory metrics stemming from international collaboration pathways and opportunities
- Gain insights on industry and patient group perspectives on collaboration pathways and future considerations
Speaker(s)
Advancing Regulatory Innovation: Canada’s Role in Global Collaboration
Kelly Robinson, MSc
Health Canada, Canada
Director General, Pharmaceutical Drugs Directorate
Enabling Faster Access and the Launch of Innovative Medicines and Vaccines
Jenny Buckley, MA, MSc
Innovative Medicines Canada, Canada
Director, Policy
What do the Metrics Tell Us
Neil McAuslane, PhD, MSc
Centre for Innovation in Regulatory Science (CIRS), United Kingdom
Scientific Director
Enhancing Patient Access to Therapies
Jessy Ranger
Myeloma Canada, Canada
Director, Patient Programs, Health Policy & Advocacy
Have an account?